[1]
“RISK OF FMF DEVELOPMENT AMONG HETEROZYGOUS PATIENTS IN ARMENIAN POPULATION”, Proc. YSU B: Chem. Biol. Sci., vol. 50, no. 3 (241), pp. 48–52, Nov. 2016, doi: 10.46991/PYSUB.2016.50.3.048.